ClinicalTrials.gg
RecruitingNCT04152109PICSUpdated May 8, 2024

Integrative and Complementary Health Practices (PICS)

An interventional study of Without laying on of hands subgroup and Laying on of hands without Spiritual connection in Neoplasms and Epilepsy, sponsored by Universidade Federal do Triangulo Mineiro. Recruiting at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-05-08.

Sponsored by Universidade Federal do Triangulo Mineiro · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 11 months ago, but the record still lists the study as recruiting.
  • Started Oct 2019; still recruiting 7 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Complementary medicine, considered an unconventional approach, is performed in conjunction with conventional medicine. In Brazil, Integrative and Complementary Practices in Health have been inserted by the National Ordinance of Integrative and Complementary Practices. The aim of this study is to evaluate the effects of laying on of hands with spiritual connection by the Spiritist Passe about mental and physical health and quality of life of individuals.

Read the detailed description

Type of study: randomized controlled trial. The sample will consist of cancer and epileptic patients including individuals aged eigtheen years and over. Patients will be referred by health professionals and social workers from Lar da Charidade, Clinics Hospital and attachments, as well as from the general community and will be invited to participate in the study at the Center for Integrative and Complementary Practices of the Clinics Hospital.

Participants will answer the questionnaires before the start of the study, after eight sessions and fiveteen days or the end of the research according to the group. The participants will be submitted to blood collection, when necessary.

02

Conditions studied

  • Neoplasms
  • Epilepsy

Keywords

  • complementary medicine
  • laying on of hands
  • cancer
  • epilepsy
  • complementary therapies
03

In context

Neoplasms

10,838 studies on the registry are indexed under Neoplasms; 2,322 are open to participants now.

This study's planned enrollment of 60 is close to the median of 60 across 7,716 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

Universidade Federal do Triangulo Mineiro is the lead sponsor of 12 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Cancer patients: diagnosis of neoplasia receiving parenteral chemotherapy.
  • Epileptic patients: clinical diagnosis of focal epilepsy

Exclusion criteria

Exclusion Criteria:

  • Cancer patients: pregnant women, unable to understand the questionnaires; non-attendance of 3 sessions of therapy application and refusal to sign the consent form.
  • Epileptic patients: people unable to understand the questionnaires; non-attendance of 3 sessions of therapy application and refusal to sign the consent form, as well as special groups (pregnant women, newly diagnosed epilepsy).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Other
    Without laying on of hands

    The patients will remain in bed supine with blindfolds. A volunteer will move close to the patient with hands behind and mentally repeat the alphabet or do count math during 5 minutes, around 8 weeks.

    Other: Without laying on of hands subgroup

  • Sham comparator
    Laying on of hands with healing intent and without Spiritual connection

    Participants included in this subgroup will be exposed to the laying on of hands with healing intent by volunteers. The patients will be blindfold in the supine bed during 5 minutes, 8 weeks.

    Other: Laying on of hands without Spiritual connection

  • Experimental
    Laying on of hands with healing intent and Spiritual connection by Spiritual "Passe"

    The participants will be subjected application of the laying on of hands by the passistas who will give the Spiritist "passe". Patients remain in the supine bed blindfolded for 5 minutes, around 8 weeks.

    Other: Laying on of hands by Spiritual "Passe"

Interventions

  • OtherWithout laying on of hands subgroup

    The patients will remain in bed supine with blindfolds. A volunteer will move close to the patient with hands behind and mentally repeat the alphabet or count during 5 minutes, around 8 weeks.

  • OtherLaying on of hands without Spiritual connection

    Participants included in this subgroup will be exposed to the laying on of hands with healing intent by volunteers. The patients will be blindfold in the supine bed during 5 minutes, around 8 weeks.

  • OtherLaying on of hands by Spiritual "Passe"

    The participants will be subjected application of the laying on of hands by the volunteer who will give the Spiritist "passe". Patients remain in the supine bed blindfolded for 5 minutes, around 8 weeks.

06

What researchers measure

Primary outcomes

  1. Anxiety

    Evaluation of Anxiety by Depression, Anxiety and Stress Scale. Scores between 0-63. Higher score indicates greater severity.

    Time frame: Change from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

  2. Stress

    Evaluation of stress by Depression, Anxiety and Stress Scale. Scores between 0-63. Higher score indicates greater severity.

    Time frame: Change from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

  3. Depression

    Evaluation of Depression by by Depression, Anxiety and Stress Scale. Scores between 0-63. Higher score indicates greater severity.

    Time frame: Change from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

Secondary outcomes

  1. Fatigue cancer patients

    Functional Assessment of Chronic Illness Scale. Higher score on the scale indicates greater fatigue level.

    Time frame: Change from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

  2. Quality of life in cancer patients

    Questionnaire developed to assess the quality of life of cancer patients. Lower score by scale indicates poorer quality of life.

    Time frame: Change from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

  3. Analysis of blood

    Blood collection for complete blood count.

    Time frame: Change from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

  4. Assessment of blood pressure

    Blood pressure, measured by the BPA 100 Microlife automatic oxygenation device

    Time frame: Change from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

  5. Assessment of peripheral oxygen saturation

    Peripheral oxygen saturation by the fingertip handheld pulse oximeter

    Time frame: Change from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

  6. Assessment of heart rate

    Heart rate (HR) by the fingertip handheld pulse oximeter.

    Time frame: Change from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

  7. Quality of life in epileptic patients

    Quality of life in epileptic patients by EQ-5D

    Time frame: Change from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

  8. Fatigue in epileptic and cancer patients

    Fatigue in epileptic and cancer patients by Fatigue pictogram. Scores between 0 - 4.

    Time frame: Change from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

  9. Brain electrical activity in epileptic patients

    Assessment of brain electrical activity in epileptic patients by electroencephalogram.

    Time frame: Change from Baseline the results anxiety at 8 weeks.

  10. Pain intensity

    Assessment of pain by Visual pain scale (VAS). Scores between 0 - 10. High scores indicates worse pain intensity.

    Time frame: Change from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

  11. Autonomic Response in epileptic patients

    Assessment of Heart rate variability by electrocardiogram with assessment of heart rate variability.

    Time frame: Change from Baseline the results anxiety at 8 weeks.

07

Study locations

1 of 1 sites recruiting
  • Núcleo de Praticas Integrativas e Complementares
    Uberaba, Minas Gerais 381000 000, Brazil
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2019 (actual). Primary completion is estimated for Dec 2025, 74 months after the start.

Of 1,993 non-industry interventional studies with no phase under Neoplasms, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 52. This study's planned 74 months is above that.

Counting every sponsor, half of 2,068 studies reached it within 29 months; a quarter within 13 and three quarters within 52.

Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 21, 2019
First posted
Nov 5, 2019
StartActual
Oct 2, 2019
Primary completionEst.
Dec 2, 2025
CompletionEst.
Dec 30, 2025
Last update
May 8, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04152109
Lead sponsor
Universidade Federal do Triangulo Mineiro
Responsible party
Elida Mara Carneiro da Silva (Doctor of Health Sciences, Universidade Federal do Triangulo Mineiro) — Principal investigator
First posted
Nov 5, 2019
Start date
Oct 2, 2019
Primary completion
Dec 2, 2025 (estimated)
Completion
Dec 30, 2025 (estimated)
Last update
May 8, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion